IRUS-ANZ has moved. From January 2022, new monthly statistics will only be added to the IRUS R5 service. This site is archived. All statistics up to December 2021 will remain available on this site.

Item Statistics

A phase I trial of imatinib in combination with mFOLFOX6-bevacizumab in patients with advanced colorectal cancer

RepositoryUniversity of Melbourne [Minerva Access]
URLhttp://hdl.handle.net/11343/219796
Author(s)orcid:0000-0003-1423-4484; orcid:0000-0002-8792-7807; orcid:0000-0001-8908-6071; Michael, M; Zalcberg, J; Gibbs, P; Lipton, L; Gouillou, M; Jefford, M; McArthur, G; Copeman, M; Lynch, K; Tebbutt, NC
Item typeArticle
JournalCancer Chemotherapy and Pharmacology, Print_ISSN:0344-5704, Online_ISSN:1432-0843
DOIhttps://doi.org/10.1007/s00280-012-2009-5

Usage Date Range

Note: Daily statistics are only available for the last six weeks.

     

Reporting Period Total 2021-12-15 2021-12-16 2021-12-17 2021-12-18 2021-12-19 2021-12-20
2 1 0 0 0 0 1
Jisc logo Cranfield logo CAVAL logo